BioCryst Pharmaceuticals Inc (BCRX)
NASDAQ
Quarter End | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 79,55M | 68,78M | 82,49M | 86,74M | 93,4M | 92,76M | 109,33M | 117,09M |
Revenu d'exploitation | -46,31M | -28,42M | -20,7M | -19,26M | -42,67M | -14,49M | 8,76M | 7,69M |
Revenu avant impôt | -71,47M | -52,66M | -74,59M | -35,82M | -63,16M | -35,01M | -12,5M | -13,45M |
Revenu net | -71,54M | -53,33M | -75,33M | -36,15M | -61,73M | -35,38M | -12,67M | -14,03M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -46,31M | -28,42M | -20,7M | -19,26M | -42,67M | -14,49M | 8,76M | 7,69M |
EBITDA | -45,92M | -28,01M | -20,3M | -18,84M | -40,7M | -14,18M | 9,08M | 8M |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 26,35M | 25,19M | 20,65M | 48,84M | 17,81M | 157,17M | 270,83M | 331,41M |
Revenu d'exploitation | -48,61M | -57,41M | -94,22M | -99,46M | -174,76M | -177,72M | -148,44M | -103,71M |
Revenu avant impôt | -55,14M | -65,78M | -101,25M | -108,9M | -182,81M | -181,81M | -244,38M | -226,23M |
Revenu net | -55,14M | -65,78M | -101,25M | -108,9M | -182,81M | -184,06M | -247,12M | -226,54M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | -0.747 | -0.668 | -0.92 | -0.707 | -1.034 | -0.998 | -1.315 | -1.106 |
EBIT | -48,61M | -57,41M | -94,22M | -99,46M | -176,77M | -177,72M | -148,44M | -103,71M |
EBITDA | -48,12M | -56,71M | -93,45M | -98,73M | -174,01M | -176,94M | -147M | -100,51M |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales